Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America”

3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,063
Index total 30,257
Page 39 / 128

Quick answer

This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,063 results for “The United States of America” · 30,257 patents in full index Clear search

  1. US 9868769

    Mutated Salmonella enteriaca

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 16, 2018 · Expires Jan 11, 2038

    granted

  2. US 9862679

    Potent and selective inhibitors of monoamine transporters; method of making; and use thereof

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted

  3. US 9861681

    Therapeutic compositions for neutralizing type I interferons, and methods of use

    The United States of America as represented by the Secretary of the Army, on behalf of the United States Army Medical Research Institute of Infectious Diseases · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted

  4. US 9855298

    Methods of conditioning patients for T cell therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  5. US 9856313

    Epitope of RSV fusion protein and antibody recognizing the same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  6. US 9855330

    Granulysin in immunotherapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  7. US 9856204

    Methods for inhibiting muscle atrophy

    THE UNITED STATES OF AMERICA AS REPRESENTED BY VETERANS AFFAIRS · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  8. US 9855312

    GHRH agonists for the treatment of ischemic disorders

    THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  9. US 9856453

    Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  10. US 9850468

    Infectious hepatitis E virus genotype 3 recombinants

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 26, 2017 · Expires Dec 21, 2037

    granted

  11. US 9845350

    Monoclonal antibodies that react with the capsule of bacillus anthracis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 19, 2017 · Expires Dec 14, 2037

    granted

  12. US 9833519

    Methods for the diagnosis and treatment of sjögren's syndrome

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 5, 2017 · Expires Nov 30, 2037

    granted

  13. US 9833437

    Small molecule inhibitor of MYD88 for therapeutic treatment against alphavirus and staphylococcal enterotoxin infections and toxin exposure

    The United States of America as represented by the Secretary of the Army · Granted Dec 5, 2017 · Expires Nov 30, 2037

    granted

  14. US 9833468

    Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Dec 5, 2017 · Expires Nov 30, 2037

    granted

  15. US 9827223

    Selective ablation of pain-sensing neurons by administration of a vanilloid receptor agonist

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 28, 2017 · Expires Nov 23, 2037

    granted

  16. US 9820965

    Biologically active macrolides, compositions, and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted

  17. US 9821029

    Methods of reducing salmonella in poultry

    The United States of America, as represented by the Secretary of Agriculture · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted

  18. US 9822162

    Anti-human papillomavirus 16 E6 T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted

  19. US 9814771

    Live attenuated classical swine fever vaccine based in genetic manipulation of a putative fusion peptide area in the virus structural glycoprotein E2

    The United States of America, as represented by the Secretary of Agriculture · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted

  20. US 9815887

    Monoclonal antibodies that neutralize a norovirus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted

  21. US 9808458

    Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 7, 2017 · Expires Nov 2, 2037

    granted

  22. US 9809643

    Identification of antibodies specific for at least two different lyssaviruses

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 7, 2017 · Expires Nov 2, 2037

    granted

  23. US 9808520

    Rationally developed african swine fever attenuated virus strain protects against challenge with parental virus georgia 2007 isolate

    The United States of America, as represented by the Secretary of Agriculture · Granted Nov 7, 2017 · Expires Nov 2, 2037

    granted

  24. US 9809824

    CpG oligonucleotide prodrugs, compositions thereof and associated therapeutic methods

    THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Nov 7, 2017 · Expires Nov 2, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.